Jacob S Aday (Jacob Aday)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Borderline Personality Disorder

Top Venues

Psychopharmacology

Journal of psychoactive drugs

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob S Aday, David Horton, Gisele Fernandes-Osterhold, Aoife O'Donovan, Ellen R Bradley, Raymond C Rosen, Joshua D Woolley
Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology (2024)
Jacob S Aday, David Horton, Gisele Fernandes-Osterhold, Aoife O'Donovan, Ellen R Bradley, Raymond C Rosen, Joshua D Woolley
Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology 241 (8) (2024)
Jacob S Aday, Emily K Bloesch, Alan K Davis, Sarah E Domoff, Kyle Scherr, Josh D Woolley, Christopher C Davoli
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study. Journal of psychoactive drugs (2024)
Jacob S Aday, David Horton, Gisele Fernandes-Osterhold, Aoife O'Donovan, Ellen R Bradley, Raymond C Rosen, Joshua D Woolley
Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology 241 (8) (2024)
Jacob S Aday, Lin Fang, Joshua M Carlson
Eye-size effects in the dot-probe task: Greater sclera exposure predicts delayed disengagement from fearful faces. PloS one 18 (5) (2023)
Jacob S Aday, Lin Fang, Joshua M Carlson
Eye-size effects in the dot-probe task: Greater sclera exposure predicts delayed disengagement from fearful faces. PloS one 18 (5) (2023)
Jacob S Aday, Lin Fang, Joshua M Carlson
Eye-size effects in the dot-probe task: Greater sclera exposure predicts delayed disengagement from fearful faces. PloS one 18 (5) (2023)
Anne Katrin Schlag, Jacob S Aday, Iram Salam, Joanna Neill, David J Nutt
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of psychopharmacology (Oxford, England) 36 (3) (2022)
Jacob S Aday, Boris D Heifets, Steven D Pratscher, Ellen Bradley, Raymond Rosen, Joshua D Woolley
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology 239 (6) (2022)
Ben Sessa, Jacob S Aday, Steve O'Brien, H Valerie Curran, Fiona Measham, Laurie Higbed, David J Nutt
Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA. Journal of psychopharmacology (Oxford, England) 36 (3) (2021)
Jacob S Aday, Christopher C Davoli, Emily K Bloesch
Psychedelics and virtual reality: parallels and applications. Therapeutic advances in psychopharmacology 10 (2020)
Jacob S Aday, Christopher C Davoli, Emily K Bloesch
Slowhand: Does time perception change in peri-hand space? Psychonomic bulletin & review 26 (4) (2019)
Jacob S Aday, Emily K Bloesch, Christopher C Davoli
Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century. Journal of psychoactive drugs 51 (3) (2019)
Jacob S Aday, Joshua M Carlson
Extended testing with the dot-probe task increases test-retest reliability and validity. Cognitive processing 20 (1) (2018)